Humanigen (HGEN) Financials

$0.00

$0.00 (0.00%)

As on 07-Mar-2024 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

9.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	1.70	2.51	3.60	0.31	--	--
Cost of Revenue	--	--	--	--	2.15	1.77
Gross Profit	1.70	2.51	3.60	0.31	-2.15	-1.77
Operating Expenses	53.71	70.82	236.37	88.51	8.94	11.33
Operating Profit (EBIT)	-52.01	-68.30	-232.77	-88.20	-8.94	-11.33
Other Income	--	--	-1.61	0.00	0.00	0.18
Profit before Tax	-53.63	-70.73	-236.65	-89.54	-10.29	-12.00
Provision for Tax	-0.50	-0.49	2.26	1.34	1.35	0.18
Profit after Tax (Net Income)	-53.30	-70.24	-238.91	-90.87	-11.64	-12.00
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-53.84	--	-236.65	-89.54	-10.29	-12.00

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-49.73	-46.77	-23.69	45.55	-14.32	-8.11
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.55	1.77	26.02	2.34	1.25	1.22
Current Liabilities	53.30	56.19	68.73	20.42	13.59	8.26
Total Liabilities	58.41	11.20	71.06	68.30	0.52	1.37

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.09	0.09	0.09	0.09	0.07	0.07
Current Assets	5.03	11.11	70.97	68.21	0.45	1.30
Total Assets	58.41	11.20	71.06	68.30	0.52	1.37
Total Debt*	--	--	25.01	--	6.49	3.50
Net Current Assets	-48.27	-45.09	2.25	47.80	-13.14	-6.96

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-76.70	-184.05	-69.85	-4.00	-6.21
Cash Flow from Investing Activities	--	--	--	-0.02	-0.02	-0.02
Cash from Financing Activities	--	16.84	186.32	137.47	3.33	6.26
Net Cash Inflow / Outflow	--	--	2.28	67.59	-0.67	0.05

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.62	-1.18	-3.78	-1.76	-0.51	-0.55
Cash EPS ($)	--	-1.18	-3.78	-1.76	-0.51	-0.54
Adjusted Book Value ($)	--	--	--	0.88	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.29	-2.91	-1.35	-0.18	-0.28
Free Cash Flow per Share ($)	--	-1.29	-2.91	-1.35	-0.18	-0.28

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	309.10	-1,019.62	-481.90	187.10	250.55
ROE (%)	--	199.39	-2,186.15	-582.00	103.83	73.99
ROA (%)	-53.06	-170.78	-342.86	-264.06	-1,230.11	-789.74
EBIT Margin (%)	-3,061.21	-2,716.95	-6,474.88	-28,268.59	--	--
Net Margin (%)	-3,137.32	-2,793.87	-12,054.14	-29,218.97	1,164,300.00	-6,706.15
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-59.01	-0.30	10.52	--	--	--
EBIT Growth (%)	72.47	70.66	-163.92	-886.11	18.74	40.82
Net Profit Growth (%)	72.29	70.60	-162.91	-680.48	3.01	45.40
EPS Growth (%)	80.56	0.69	-1.15	-2.42	0.06	0.93
Book Value Growth (%)	-9.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.10	-0.98	-9.96	-0.95	-1.28
Price / Book Value	9.20	-0.15	-9.92	19.88	-0.77	-1.90
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.42	0.04	-0.81	-9.50	-1.94	-1.65
Close Price ($)	0.14	0.12	3.72	17.50	2.44	3.50
High Price ($)	3.39	4.11	29.20	33.95	7.72	4.40
Low Price ($)	0.09	0.09	3.63	1.50	1.50	1.35
Market Cap ($ Cr)	0.02	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	-1.06	--	-0.45	-0.43
Short term debt to equity ratio	--	--	--	0.12	-0.37	-0.28
Current Ratio	0.09	0.20	1.03	3.34	0.03	0.16
Quick Ratio	0.09	--	--	--	--	--
Interest Coverage	-23.36	-23.41	-102.81	-66.02	-6.63	-12.92

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.02	0.06	0.05	0.01	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	671.21	639.34
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.